• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于分子模拟从中药中发现具有潜在降压活性的ATP敏感性钾通道开放剂

[Discovery of potential ATP-sensitive potassium channel openers with potential hypotensive activity from Chinese herbs based on molecular simulation].

作者信息

Li Yong, Jiang Lu-di, Chen Xi, He Yu-Su, Li Gong-Yu, Zhang Yan-Ling

机构信息

Beijing University of Chinese Medicine, Research Center of Traditional Chinese Medicine information Engineering, Beijing 100102, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2016 Jan;41(2):264-271. doi: 10.4268/cjcmm20160217.

DOI:10.4268/cjcmm20160217
PMID:28861972
Abstract

In this research, a combined method of ligand-based pharmacophore (LBP), structure-based pharmacophore (SBP), and molecular docking was applied for virtual screening potential ATP-sensitive potassium channel (KATP) openers from Chinese herbs. LBP models were generated by 3D-QSAR pharmacophore(hypogen) program, based on the training set composed of 48 KATP agonists. The best LBP model consisted of one hydrogen-bond acceptor, one hydrogen-bond donor, one hydrophobic feature, one aromatic ring and five excluded volumes. Besides, the correlation coefficient of training set and test set, N, and CAI value of the model were 0.876 4, 0.705 8, 3.304, and 2.616 respectively. Meanwhile, SBP models were also generated based on a 3D structure of KATP (PMID: PM0079770). The best SBP model consisted of six hydrogen-bond acceptors, eight hydrogen-bond donors, seven hydrophobic features and eighteen excluded volumes. The corresponding N and CAI value were 2.200 and 2.017. Then, the best LBP model and SBP model were applied to identify potential KATP openers from Traditional Chinese Medicine Database(TCMD), respectively. 349 hits were obtained after analyzed by drug-likeness rules. Moreover, 12 compounds with high docking scores were reserved after molecular docking evaluation. Interestingly, part of the results had been verified as hypotensive active ingredients by literatures. Therefore, this study uncovers a specific target effect contained in TCMD, and provides candidates for new KATP openers' research.

摘要

在本研究中,采用基于配体的药效团(LBP)、基于结构的药效团(SBP)和分子对接相结合的方法,从中药中虚拟筛选潜在的ATP敏感性钾通道(KATP)开放剂。基于由48种KATP激动剂组成的训练集,通过3D-QSAR药效团(hypogen)程序生成LBP模型。最佳的LBP模型由一个氢键受体、一个氢键供体、一个疏水特征、一个芳香环和五个排除体积组成。此外,该模型训练集和测试集的相关系数、N值和CAI值分别为0.876 4、0.705 8、3.304和2.616。同时,还基于KATP的三维结构(PMID:PM0079770)生成了SBP模型。最佳的SBP模型由六个氢键受体、八个氢键供体、七个疏水特征和十八个排除体积组成。相应的N值和CAI值分别为2.200和2.017。然后,分别将最佳的LBP模型和SBP模型应用于从中药数据库(TCMD)中识别潜在的KATP开放剂。经类药规则分析后获得349个命中结果。此外,经过分子对接评估后保留了12个对接分数高的化合物。有趣的是,部分结果已被文献证实为降压活性成分。因此,本研究揭示了中药中蕴含的特定靶点效应,并为新型KATP开放剂的研究提供了候选物。

相似文献

1
[Discovery of potential ATP-sensitive potassium channel openers with potential hypotensive activity from Chinese herbs based on molecular simulation].基于分子模拟从中药中发现具有潜在降压活性的ATP敏感性钾通道开放剂
Zhongguo Zhong Yao Za Zhi. 2016 Jan;41(2):264-271. doi: 10.4268/cjcmm20160217.
2
[Discovery of potential LXRβ agonists from Chinese herbs using molecular simulation methods].[利用分子模拟方法从中药中发现潜在的肝X受体β激动剂]
Zhongguo Zhong Yao Za Zhi. 2016 Aug;41(16):3065-3071. doi: 10.4268/cjcmm20161621.
3
[Method of traditional Chinese medicine formula design based on 3D-database pharmacophore search and patent retrieval].基于三维数据库药效团搜索和专利检索的中药方剂设计方法
Zhongguo Zhong Yao Za Zhi. 2014 Nov;39(22):4411-7.
4
[Study on lipid-lowering traditional Chinese medicines based on pharmacophore technology and patent retrieval].基于药效团技术和专利检索的降脂中药研究
Zhongguo Zhong Yao Za Zhi. 2014 Dec;39(24):4839-43.
5
Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.利用药效团、虚拟筛选和分子对接方法探索HIV蛋白酶抑制剂的结构要求以进行先导物识别。
J Mol Graph Model. 2015 Mar;56:20-30. doi: 10.1016/j.jmgm.2014.11.015. Epub 2014 Dec 5.
6
Pharmacophore, QSAR, and binding mode studies of substrates of human cytochrome P450 2D6 (CYP2D6) using molecular docking and virtual mutations and an application to chinese herbal medicine screening.基于分子对接和虚拟突变的人细胞色素 P450 2D6(CYP2D6)底物的药效团、定量构效关系和结合模式研究及其在中草药筛选中的应用。
Curr Pharm Biotechnol. 2012 Jul;13(9):1640-704. doi: 10.2174/138920112800958779.
7
Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.基于药效团生成、基于原子的 3D-QSAR、分子对接和分子动力学模拟研究苯甲酰胺类似物作为 FtsZ 抑制剂。
J Biomol Struct Dyn. 2018 Sep;36(12):3218-3230. doi: 10.1080/07391102.2017.1384401. Epub 2017 Oct 11.
8
First universal pharmacophore model for hERG1 K channel activators: acthER.首个针对人醚 - 去极化激活钾离子通道1(hERG1 K通道)激活剂的通用药效团模型:促hERG1 K通道激活模型(acthER)
J Mol Graph Model. 2017 Jun;74:153-170. doi: 10.1016/j.jmgm.2017.03.020. Epub 2017 Apr 5.
9
[Virtual screening for natural CETP inhibitors by structure-based pharmacophore].基于结构的药效团对天然胆固醇酯转运蛋白抑制剂的虚拟筛选
Zhongguo Zhong Yao Za Zhi. 2015 Aug;40(15):3063-7.
10
Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking.基于 3D-QSAR 药效团模型和分子对接预测新型钙激活氯离子通道蛋白 1(ANO1)抑制剂。
Int J Mol Sci. 2018 Oct 17;19(10):3204. doi: 10.3390/ijms19103204.

引用本文的文献

1
Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment.降糖药物利格列汀重新定位用于癌症治疗
Front Pharmacol. 2020 Mar 3;11:187. doi: 10.3389/fphar.2020.00187. eCollection 2020.
2
Identification and characterization of the structure-activity relationships involved in UGT1A1 inhibition by anthraquinone and dianthrone constituents of Polygonum multiflorum.鉴定和描述何首乌中蒽醌和二蒽酮成分对 UGT1A1 抑制作用的构效关系。
Sci Rep. 2017 Dec 20;7(1):17952. doi: 10.1038/s41598-017-18231-y.